Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

44.77
-3.8100-7.84%
Pre-market: 45.000.2300+0.51%05:21 EDT
Volume:79.63K
Turnover:3.70M
Market Cap:128.67M
PE:-1.16
High:49.20
Open:48.15
Low:44.47
Close:48.58
52wk High:240.00
52wk Low:7.88
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.28
T/O Rate:3.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:1.54
PE(LYR):-0.88

Loading ...

Spruce Biosciences names Eric Jordan as VP, Marketing

Reuters
·
Jun 15

Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller

THOMSON REUTERS
·
Jun 15

Spruce Biosciences Initiated at Buy by Jones Trading

Dow Jones
·
Jun 09

Spruce Biosciences Reports Long-Term Data for Enzyme Replacement Therapy to Treat Genetic Disease MPS IIIB

MT Newswires Live
·
Jun 09

Spruce Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
Jun 09

Spruce says long-term TA-ERT data presented at MPS Symposium

TIPRANKS
·
Jun 09

Spruce Biosciences reports six-year tralesinidase alfa data showing sustained biomarker reductions, stabilized cognition in MPS IIIB

Reuters
·
Jun 09

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (Mps Iiib) Presented at the 18TH International Mps Symposium

THOMSON REUTERS
·
Jun 09

Spruce Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Spruce Biosciences, Inc : H.c. Wainwright Cuts Target Price to $150 From $200

THOMSON REUTERS
·
Jun 01

Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium

Reuters
·
May 29

Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium

Reuters
·
May 29

Spruce Biosciences Announces Data Presentation at the 18TH International Mps Symposium

THOMSON REUTERS
·
May 29

Spruce Biosciences to present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 27

Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay

TIPRANKS
·
May 27

Spruce Biosciences shareholders elect Class III directors at annual meeting

Reuters
·
May 27

Spruce Biosciences, Inc : Leerink Partners Cuts Target Price to $120 From $140

THOMSON REUTERS
·
May 14

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 14

Spruce Biosciences price target lowered to $150 from $170 at Citizens

TIPRANKS
·
May 14